PEAK6’s Encompass Health EHC Stock Holding History

PEAK6’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-16,800	Closed	-$1.55M	–	3153
2024 Q4	$1.55M	Buy	+16,800	New	+$1.65M	﹤0.01%	1572

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PEAK6's EHC Position: Q4 2025 in Review

PEAK6 sold out of Encompass Health (EHC) in Q4 2025, closing a stake of 2,496 shares — an estimated $317K sold.

PEAK6 first reported a position in EHC in Q2 2025 and held it in 2 quarters. The position peaked at $317K in Q3 2025. 593 funds tracked by Wall St. Rank hold EHC as of Q4 2025.

PEAK6 reported no remaining Encompass Health position as of Q4 2025 after selling out during the quarter.
PEAK6 sold 2,496 Encompass Health shares in Q4 2025, an estimated $317K.
PEAK6 first reported a position in Encompass Health in Q2 2025 and held it in 2 quarters.
PEAK6's Encompass Health position peaked at $317K in Q3 2025.
593 funds tracked by Wall St. Rank held Encompass Health as of Q4 2025.

Based on PEAK6's 13F filing for Q4 2025, filed 13 Feb 2026.